Introduction {#s1}
============

Angiosarcoma is a type of malignant mesenchymal tumor which was characterized with the presence of endothelial differentiation of the tumoral cells. The bone is in an unusual localization for angiosarcoma, and skeletal lesions are clinically aggressive. High local recurrence rate, lymph node and systemic metastasis were reported \[[@R01]\]. It presents mostly in the second and seventh decades of life \[[@R01]\]. The pathological diagnosis may require several biopsies and radiological support for the certain diagnosis.

Case Report {#s2}
===========

A 31-year-old man applied to our outpatient clinic with left hip pain that lasted for 6 months. In the X-ray examination, an expansile, multilobulated and cystic mass located in the proximal part of left femur was observed. The computed tomography (CT) examination revealed a multilobulated, lytic mass of 7 cm in diameter containing thin hyperdense septum extending to the greater trochanter and neck region, which was reported as a complicated cystic mass ([Fig. 1](#F1){ref-type="fig"}).

![Preoperative X-ray and CT views of the mass. CT: computed tomography.](wjon-08-196-g001){#F1}

Magnetic resonance imaging (MRI) examination was carried out to further examine this intramedullary mass. There was an intramedullary heterogeneous cystic mass appearance in the proximal part of the left femur ([Fig. 2](#F2){ref-type="fig"}). The posterior cortex was destroyed and there was soft tissue extension resembling aneurysmal bone cyst, and Jamshidi needle biopsy was advised.

![Preoperative MRI view. MRI: magnetic resonance imaging.](wjon-08-196-g002){#F2}

The first biopsy was not definitive in describing the sample as partially degenerated bone fragment containing low degree chronic inflammation and focal fibrochondroid tissue. The second biopsy was carried out to rule out malignancy. The second biopsy revealed osteoclastic giant cells between bone lamella and proliferated vascular tissue with epithelioid morphology containing atypical fusiform cell proliferation. The immunohistochemical analysis with CD31 stain was positive supporting the diagnosis of angiosarcoma ([Fig. 3a-c](#F3){ref-type="fig"}).

![(a) Normal bone histology, × 40 magnification. (b) Hematoxylin-eosin stain. (c) Immunohistochemical stain with CD31.](wjon-08-196-g003){#F3}

The patient was treated with wide resection of the left proximal femur and partial replacement of the left hip with tumor resection prosthesis ([Fig. 4a](#F4){ref-type="fig"}). The excised proximal femur was examined pathologically to validate the diagnosis and to check the surgical borders ([Fig. 4b](#F4){ref-type="fig"}). The surgical borders were reported to be clean. The patient was undergone a regimen of chemotherapy and radiotherapy postoperatively. X-rays and positron emission tomography (PET) scan in the 18th month postoperatively revealed no metastasis. There was no complication or surgical site infection. The patient returned to the daily life, and has been followed up regularly in every 3 months.

![(a) Postoperative X-ray. (b) Excised sample of bone.](wjon-08-196-g004){#F4}

Discussion {#s3}
==========

Primary vascular bone tumors are extremely rare. Angiosarcoma is a malignant vascular endothelial tumor which selects soft tissue locations mostly. Primary angiosarcoma of bone constitutes less than 1% of bone tumors \[[@R02]\]. These tumors exert male predominance. The angiosarcoma of bone may be localized in both short and long bones of the skeleton; femur, tibia and humerus are the most probable locations \[[@R03]\].

The etiology of malignant vascular bone tumors is unclear. The early diagnosis with biopsy may be the only chance of the patient to survive. The definitive diagnosis is done with histological and immunohistochemical tests \[[@R04]\]. The key of the immunohistochemical examination is the application of vascular markers for the diagnosis of epithelioid angiosarcoma. The most sensitive vascular marker is CD31 \[[@R05]\]. Factor VIII and CD34 markers are the other useful markers for diagnostic studies. Desphande et al examined 10 patients and proved 75% patients as positive with factor VIII and 40% patients as positive with CD34 markers \[[@R05]\]. Our patient was stained positive with the most sensitive marker, CD31.

Epithelioid angiosarcoma hosts a potential risk of delayed diagnosis due to its very rare occurance and misinterpretations as metastatic carcinoma mostly as renal cell carcinoma. The other possible options of misdiagnoses are vascular tumors mostly the hemangioma and low grade angiosarcoma. Basillary angiomatosis is a process characterized with vascular proliferation, epithelioid endothelial cells showing cytological atypia. The differential diagnosis of basillary angiomatosis is done easily in the presence of bacterial clusters and neutrophilic proliferation.

Different from common attitude of soft tissue sarcomas, which selectively metastasize to lungs, epithelioid angiosarcoma metastasize to lymph nodes and solid organs. Lungs, bone, soft tissues and skin are the possible locations of metastasis. More than 50% of patients diagnosed as epithelioid angiosarcoma are lost in 3 years \[[@R01], [@R05]\]. The treatment alternatives are similar to bone sarcomas; amputation, radical resection combined with radiotherapy and/or chemotherapy \[[@R06]-[@R08]\].

Fluorodeoxyglucose PET (FDG-PET) is a very useful device as a postoperative follow-up tool to rule out lymph node metastasis \[[@R9], [@R10]\]. Our patient is screened with FDG-PET in 3 monthly periods and he is in the 18th month postoperatively free of local recurrence or metastasis.

Conclusions {#s3a}
-----------

Bone angiosarcoma is one of the diagnoses that should be kept in mind in cases of difficulty in diagnosis. With early diagnosis and good surgical treatment, life expectancy is increasing.
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